Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

Q: What does CUSIP 15673T100 represent in this 13F holders report?

CUSIP 15673T100 is the security identifier for IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q4 2024?

70 institutional investors reported IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q4 2024. Use the holders table for investor-level position and value details.

CUSIP: 15673T100

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 180,747,818
Total 13F shares: 36,396,514
Share change: -3,450,296
Total reported value: $36,761,199
Put/Call ratio: 15%
Reported price per share: $1.01
Number of holders: 70
Value change: -$7,768,598
Number of buys: 41
Number of sells: 20

Security key

15673T100

Report period

Q4 2024

Institutions

Top holders

IPSC full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2025 Previous quarter: Q3 2024 Century Therapeutics, Inc. SEC filings Century Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 15673T100

Newer quarter: Q1 2025 Previous quarter: Q3 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Bain Capital Life Science...

13D/G signal

—

Evidence rows

Latest as of

30 Sep 2024

13F Lead comparable stake: 3% Showing 1-6 of 15 holder rows.

Rank 1 holder

Bain Capital Life Sciences Investors, LLC

13F

Ownership: 3%
Position: $9.25M

13F

Rank 2 holder

Venrock Adviser, LLC

13F

Ownership: 3%
Position: $9.22M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Bain Capital Life Sciences Investors, LLC	13F Company 13F	3%	$9,251,717 5,410,361 shares	—	30 Sep 2024
Venrock Adviser, LLC	13F Company 13F	3%	$9,215,633 5,389,259 shares	—	30 Sep 2024
Boxer Capital, LLC	13F Company 13F	2.2%	$6,669,000 3,900,000 shares	—	30 Sep 2024
Casdin Capital, LLC	13F Company 13F	1.8%	$5,493,060 3,212,316 shares	—	30 Sep 2024
BlackRock, Inc.	13F Company 13F	1.7%	$5,112,764 2,989,920 shares	—	30 Sep 2024
FMR LLC	13F Company 13F	1.4%	$4,311,784 2,521,511 shares	—	30 Sep 2024

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

36,396,514

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

Q4 2024 holders

Holder diff

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 value	Q4 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend